WebOPT OPTHEA LIMITED Market Cap $345.6M ! Add to my watchlist Overview Discussion Corporate Spotlight More Corporate Spotlight Not Yet Available Are you a Company Director ? Put your Investment Case to Hotcopper's 700K monthly unique visitors. Claim your IR profile See benefits Latest Threads See All Discussions Timeline WebMELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to …
Opthea Treats First Patient in Phase 3 Pivotal Trials of OPT-302 in …
WebMar 15, 2024 · Opthea (ASX:OPT; Nasdaq: OPT) is a biopharmaceutical company developing a novel therapy to address the unmet need in the treatment of highly prevalent and … WebOpthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatmentof eye diseases. dfa investment philosophy
OPT: Opthea Ltd - Stock Price, Quote and News - CNBC
WebApr 14, 2024 · The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated … WebOpthea Limited American Depositary Shares (OPT) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Charts Key Data Bid Price and Ask Price The bid … WebOct 12, 2024 · Our data indicates that Opthea Limited has a market capitalization of AU$446m, and total annual CEO compensation was reported as US$531k for the year to June 2024. We note that's a decrease of... church\\u0027s furniture geneva ny